Appili Therapeutics Reports Financial and Operational
FDA approved LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL Additional USAFA funding commitment from the U.S. Air Force Academy, intended ...
Read moreFDA approved LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL Additional USAFA funding commitment from the U.S. Air Force Academy, intended ...
Read moreIn a strategic move set to reshape its operational landscape, Subham proudly announces the opening of its latest warehouse ...
Read moreVerizon consistently improves its solutions via market research and customer feedback, ensuring it meets clients' needs and performs optimally compared ...
Read moreTORONTO, Nov. 14, 2023 /PRNewswire/ -- The INX Digital Company, Inc. (NEO: INXD, OTCQB: INXDF, INXATS: INX) (the "Company" or "INX"), the owner ...
Read moreMedidata's Rave Grants Manager will be implemented across 50 multinational studies and multiple therapeutic areas SYDNEY, Nov. 14, 2023 /PRNewswire/ -- Medidata, a ...
Read moreCompleted enrollment in pivotal Phase 3 “DRAGON” trial for Tinlarebant in adolescent Stargardt disease (“STGD1”) with 104 subjects enrolled across ...
Read moreTokyo, Japan and Cambridge, UK, 10 November 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) provides ...
Read moreFRAMINGHAM, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and ...
Read moreNew relationship is latest in string of partnerships designed to advance development of Supernal's vision for AAM Supernal LLC – ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.